Welcome to CDC stacks | Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients - 18421 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients
  • Published Date:
    Nov 2010
  • Source:
    Emerg Infect Dis. 16(11):1809-1811.
Filetype[PDF-96.30 KB]


No Related Documents.
You May Also Like:
  1. H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients
    Personal Author:
    Renaud, Christian; Boudreault, Alexandre A.; Kuypers, Jane; Lofy, Kathryn H.; Corey, Lawrence; Boeckh, Michael J.; Englund, Janet A.;
    Published:
    Apr 2011
    Source:
    Emerg Infect Dis. 17(4):653-660.
    Description:
    Most oseltamivir-resistant pandemic (H1N1) 2009 viruses have been isolated from immunocompromised patients. To describe the clinical features, treatment, outcomes, and virologic data associated with infection from pandemic (H1N1) 2009 virus with H275...
    File Type:
    Filetype[PDF - 420.34 KB]
  2. Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
    Personal Author:
    Tramontana, Adrian R.; George, Biju; Hurt, Aeron C.; Doyle, Joseph S.; Langan, Katherine; Reid, Alistair B.; Harper, Janet M.; Thursky, Karin; Worth, Leon J.; Dwyer, Dominic E; Morrissey, C. Orla; Johnson, Paul D.R.; Buising, Kirsty L.; Harrison, Simon James; Seymour, John F.; Ferguson, Patricia E.; Wang, Bin; Denholm, Justin T.; Cheng, Allen C.; Slavin, Monica;
    Published:
    Jul 2010
    Source:
    Emerg Infect Dis. 16(7):1068-1075.
    Description:
    We describe laboratory-confirmed influenza A pandemic (H1N1) 2009 in 17 hospitalized recipients of a hematopoietic stem cell transplant (HSCT) (8 allogeneic) and in 15 patients with malignancy treated at 6 Australian tertiary centers during winter 20...
    File Type:
    Filetype[PDF - 165.50 KB]
  3. Drug-Resistant Pandemic (H1N1) 2009, South Korea1
    Personal Author:
    Shin, Soo Youn; Kang, Chun; Gwack, Jin; Kim, Joon Hyung; Kim, Hyun Su; Kang, Young A; Lee, Ha Gyung; Kim, Jin Seok; Lee, Jong-Koo; Kim, Sung-Han;
    Published:
    Apr 2011
    Source:
    Emerg Infect Dis. 17(4):702-704.
    Description:
    Eleven patients with drug-resistant pandemic (H1N1) 2009 were identified in South Korea during May 2009-January 2010. Virus isolates from all patients had the H275Y mutation in the neuraminidase gene. One isolate had the I117M mutation. Of the 11 pat...
    File Type:
    Filetype[PDF - 157.77 KB]
  4. Two Clusters of HIV-1 Infection, Rural Idaho, USA, 2008
    Personal Author:
    Nett, Randall J.; Bartschi, Jared L.; Ellis, Giovanina M.; Hachey, David M.; Frenkel, Lisa M.; Roscoe, J. Clay; Carter, Kris K.; Hahn, Christine G.;
    Published:
    Nov 2010
    Source:
    Emerg Infect Dis. 16(11):1807-1809.
    File Type:
    Filetype[PDF - 80.70 KB]
  5. Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
    Personal Author:
    Graitcer, Samuel B.; Gubareva, Larisa; Kamimoto, Laurie; Doshi, Saumil; Vandermeer, Meredith; Louie, Janice; Waters, Christine; Moore, Zack; Sleeman, Katrina; Okomo-Adhiambo, Margaret; Marshall, Steven A.; St. George, Kirsten; Pan, Chao-Yang; LaPlante, Jennifer M.; Klimov, Alexander; Fry, Alicia M.;
    Published:
    Feb 2011
    Source:
    Emerg Infect Dis. 17(2):255-257.
    Description:
    During April 2009-June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant. Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and had...
    File Type:
    Filetype[PDF - 132.32 KB]